Garcia del Moral R, Gomez-Morales M, Cortes V, Aguayo M L, Gigosos R L, Lardelli P, Navas A, Aneiros J, Aguilar D
Department of Pathology, University Hospital, Granada, Spain.
Nephron. 1993;65(2):215-21. doi: 10.1159/000187477.
Glomerular and interstitial leukocyte subpopulations were analyzed in renal biopsies from 18 patients with IgM mesangial proliferative glomerulonephritis (IgM MPGN), 19 patients with minimal change nephrotic syndrome (MC) and 10 patients with immune-negative mesangial proliferative glomerulonephritis (IN MPGN), by immunoperoxidase techniques with monoclonal antibodies. Mesangial cell proliferation was strongly correlated with absolute numbers of intraglomerular T lymphocytes (r = 0.71; p < 0.01) in IgM MPGN, but not in MC or IN MPGN. Significant differences were found in the numbers of macrophages, CD4- and CD8-positive glomerular cells (Student's t test p < 0.01, 0.05 and 0.01, respectively) in IgM MPGN, but not in MC or IN MPGN. The numbers of CD45-, CD3- and CD8-positive cells also differed in each patient group (ANOVA p < 0.01, 0.05 and 0.05, respectively), the greatest and smallest values appearing in IgM MPGN and MC, respectively. Multiple regression test showed initial proteinuria values in IgM MPGN to be closely dependent on the density of neutrophils, macrophages, T and B lymphocytes and CD4 cell inflammatory infiltrates (r2 = 0.92; p < 0.01). At the end of the follow-up, proteinuria in IgM MPGN, but not in MC or IN MPGN, was dependent on T cell infiltrate (r2 = 0.97; p < 0.01). Our findings suggest that proteinuria in IgM MPGN results from local mesangial damage rather than from the effects of a soluble circulating factor, as has been proposed for MC. The clinical and immunohistochemical differences observed between these two processes support the notion that they should be considered as separate entities.
采用单克隆抗体免疫过氧化物酶技术,对18例IgM系膜增生性肾小球肾炎(IgM MPGN)患者、19例微小病变肾病综合征(MC)患者和10例免疫阴性系膜增生性肾小球肾炎(IN MPGN)患者的肾活检组织中的肾小球和间质白细胞亚群进行了分析。在IgM MPGN中,系膜细胞增殖与肾小球内T淋巴细胞的绝对数量密切相关(r = 0.71;p < 0.01),而在MC或IN MPGN中则无此相关性。IgM MPGN患者的巨噬细胞、CD4和CD8阳性肾小球细胞数量存在显著差异(Student t检验,p分别< 0.01、0.05和0.01),而MC或IN MPGN患者则无差异。每个患者组中CD45、CD3和CD8阳性细胞的数量也有所不同(方差分析,p分别< 0.01、0.05和0.05),最高值和最低值分别出现在IgM MPGN和MC中。多元回归分析显示,IgM MPGN患者的初始蛋白尿值与中性粒细胞、巨噬细胞、T和B淋巴细胞以及CD4细胞炎症浸润的密度密切相关(r2 = 0.92;p < 0.01)。随访结束时,IgM MPGN患者的蛋白尿依赖于T细胞浸润(r2 = 0.97;p < 0.01),而MC或IN MPGN患者则不然。我们的研究结果表明,IgM MPGN患者的蛋白尿是由局部系膜损伤引起的,而不是像MC那样由可溶性循环因子的作用所致。这两个过程在临床和免疫组化上的差异支持了它们应被视为不同实体的观点。